COVID-19:Civil society open letter, urging Gilead to ensure access to potential treatment
We joined other organizations around the world to demand Gilead to take immediate actions to ensure rapid availability, affordability and accessibility of its experimental therapy Remdesivir for the treatment of COVID-19, if the clinical trials results demonstrate efficacy. The FDA granted the request to Gilead on Monday March 30th, 2020.…








